|
Omega Diagnostics Group PLC on Monday said it has signed a partnership agreement with an unnamed nutrigenomics software provider to develop and commercialise a bespoke DNA report.
Omega is a Scotland-based medical diagnostics company focused on promoting a "personalised and functional" approach to health and nutrition.
The new DNA report is intended to be used by healthcare professionals and their patients. It will be a "unique" and proprietary software tool which will expand Omega's product portfolio in line with its strategy to broaden its menu of tests.
Omega said both parties will collaborate to improve the awareness and understanding in the market of nutrigenomic testing, including the publication of educational materials and scientific studies.
The agreement follows on from the microbiome testing partnership which was announced on October 26 and, once completed, will conclude the company's initial product range expansion.
"We are pleased to have signed this second strategic partnership, this time with a leading nutrigenomics software provider, which will give the company a broader and complementary range of tests to help manage gut health and improve patient outcomes for those living with chronic diseases," Jag Grewal, chief executive officer of Omega Diagnostics said.
He added: "Our focus remains on commercial and service development within the sector, as we seek to grow revenues and further consolidate our established market leading position, thus enabling the Board's vision of delivering personalised nutrition for better health."
Shares in Omega were down 4.9% to 2.62 pence on Monday afternoon in London.
Copyright 2022 Alliance News Limited. All Rights Reserved.
|
